Navigation Links
Summit Brings Major Non-Profits, Venture, Pharma and Academics Together
Date:8/26/2013

more about the ALS TDI Leadership Summit and to register, please visit www.als.net/summit.  

About ALS
Amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) is a progressive neurodegenerative disease that leads to paralysis, due to the death of motor neurons in the spinal cord and brain. There is no known cure for the disease. About 5,000 people in the US are diagnosed with ALS each year; the incidence is similar to multiple sclerosis. However, with no effective treatment, the average patient survives only two to five years following diagnosis. There are about 30,000 people in the US diagnosed with ALS today. The worldwide population of ALS patients is estimated at 450,000.

About ALS Therapy Development Institute (ALS TDI)
The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) as soon as possible for patients today. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust target discovery program, while simultaneously operating the world's largest efforts to preclinically determine the efficacy of potential therapeutics, including a pipeline of dozens of small molecules, protein biologics, gene therapies and cell-based constructs. The world's first nonprofit biotech institute, ALS TDI employs 30 professional scientists, evaluates dozens of potential therapeutics each year and is currently executing a Phase IIA clinical trial of TDI-132 (Novartis' Gilenya®) in ALS patients.  Built by and for patients, the Cambridge, Massachusetts-based research institute collaborates with leaders in both academia and industry to accelerate ALS the
'/>"/>

SOURCE ALS Therapy Development Institute
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Fluke Biomedical to hold first Medical Device QA Training Summit
2. C to C Collaborations Foreseen at the Global Economic Summit 2013
3. GDS International Leads the Way for the Pharmaceutical Industry at its Upcoming NGP DD 30 Summit in Madrid
4. MRI Interventions CEO to Present at 2013 Brain Tumor Biotech Summit regarding MRI-Guided Therapies for Brain Cancer
5. BPSAs 3rd Annual Summit to Focus on Next Decade for Single-Use Biomanufacturing
6. 2013 Armada Specialty Pharmacy Summit Reports Record Attendance
7. Smart Water Leadership Summit Focused On Waterborne Disease Prevention in Healthcare Facilities To Be Held In Chicago June 6 & 7
8. Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
9. Afya Foundation Donates Duffels Of Medical Supplies To African First Ladies At Summit In Los Angeles
10. CADCA Chairman And CEO To Discuss Costs Of Prescription Drug Abuse At National Rx Drug Abuse Summit
11. Plato BioPharma Presenting Preclinical capabilities at PKPD Summit Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 As health officials across the ... select Meijer pharmacies in Michigan will ... eligible patients, enabling Meijer pharmacists to administer tests and, in ... by a physician participating in the study. The ...
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate of ... an at-the-market registered direct offering, led by a dedicated ... definitive purchase agreements with these investors pursuant to which ...
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... 2010 Renal Advantage and Liberty Dialysis, which last month ... dialysis services in the U.S., today announced that they have ... not disclosed – was completed on December 17, 2010.  The ... in 260 locations in 32 states. "The completion ...
... 22, 2010 Particle Sciences Inc. (PSI), a leading ... that, when coupled with an antigen, enhanced its immunogenicity, ... work is described in Vaccine , 2010 Dec. ... strong systemic and mucosal cellular and humoral immune responses ...
Cached Medicine Technology:Renal Advantage and Liberty Dialysis Deal Completed 2Renal Advantage and Liberty Dialysis Deal Completed 3Particle Sciences Develops Wax Nanoparticles that Enhance Immune Response to Antigens 2
(Date:4/17/2014)... Boston University School of Medicine (BUSM) have discovered ... in an experimental model. The findings, reported in ... Abuse , may lead to more effective treatments ... one of the leading causes of illness and ... economic impact by limiting the productivity of workers ...
(Date:4/17/2014)... team led by researchers at UC Davis has shown ... key role in cell division, also boosts the mitochondrial ... time the complex has been shown to perform both ... excellent target to control cellular energy production, potentially advancing ... online today in the journal Developmental Cell . ...
(Date:4/17/2014)... led by Cesar A. Arias, M.D., Ph.D., at The ... has identified a new superbug that caused a bloodstream ... the April 17 issue of The New England ... part of a class of highly-resistant bacteria known as ... a major cause of hospital and community-associated infections. The ...
(Date:4/17/2014)... uncommon these days to find a colored ribbon representing a ... cancer. But what color ribbon does one think of with ... color, for many suffering from the disease, black may be ... study consisting of lung cancer patients, primarily smokers between the ... light on the stigma often felt by these patients, the ...
(Date:4/17/2014)... alleviates muscle soreness after exercise, according to a ... at Chicago. , The study, reported online in ... Physical Medicine and Rehabilitation , also showed that ... not exercised, suggesting that massage has benefits for ... , Improved circulation and relief of muscle soreness ...
Breaking Medicine News(10 mins):Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:New MRSA superbug emerges in Brazil 2Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Massage therapy improves circulation, eases muscle soreness 2
... investments in nanoscale science and engineering will create revolutions ... treatment, and space travel. The hope is that many ... nanotechnology enabled products. While new technologies often do ... other social problems or create entirely new ones. The ...
... Reporter , THURSDAY, Nov. 18 (HealthDay News) -- Patients in ... because of cost than residents of other developed countries, a ... industrialized countries, the United States also has the highest out-of-pocket ... "The 2010 survey findings point to glaring gaps in ...
... into mice with metastatic melanoma has resulted in permanent ... cancer, according to an article to be published in ... Clinical Investigation . The online version is now available. ... modified lentivirus to introduce a potent anti-melanoma T cell ...
... nice extra, not a strategic imperative. But the data demonstrate ... L. Berry of Texas A&M University, Ann M. Mirabito of ... Texas MD Anderson Cancer Center. Their research shows that ... is impressive sometimes as high as six to one. ...
... WASHINGTON, Nov. 18, 2010 The latest episode in ... Global Challenges/Chemistry Solutions ," focuses on development and successful ... kills up to 98 percent of disease-causing bacteria in ... technology could aid many of the almost one billion ...
... Ill. -- Taking time off from certain osteoporosis drugs may ... at Loyola University Health System. Researchers found that bone density ... drug holiday from bisphosphonates, a popular class of osteoporosis drugs ... decay in the jaw bone. "These drugs are potentially ...
Cached Medicine News:Health News:Nanotechnology and equity issues explored in new book 2Health News:On Health Policies, U.S. Lags Other Nations: Survey 2Health News:On Health Policies, U.S. Lags Other Nations: Survey 3Health News:On Health Policies, U.S. Lags Other Nations: Survey 4Health News:Gene therapy for metastatic melanoma in mice produces complete remission 2Health News:Wellness programs provide high returns, research reveals 2Health News:Taking a break from osteoporosis drugs can protect bones 2
... 3 mirror lenses featuring ultra-clear Volk 3-Mirror ... 76°, 66° and 60°. The 3 ... well central and peripheral fundus viewing and ... angled to eliminate gaps in the visualized ...
... are a family of single-use direct view vitrectomy ... particular region of the retinal surface during eye ... 1 gram and is formed and polished to ... human cornea. Lenses come in boxes of 10 ...
... AFX Lens is a direct ... in an air-filled eye. In ... a primary air-fluid exchange vitrectomy ... sutureless design make it well ...
... Prism are designed for midperipherical ... for tractional retinal detachments (PDR, ... detachment. They can be used ... midperipheral laser applications. Direct image ...
Medicine Products: